Skip to main content

Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinical Trial Not Allowed)

Agency: National Institutes of Health

Assistance Listings
  • 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research

Archived opportunityLast Updated: May 13, 2026

Important dates

  • Archived: April 10, 2026
  • Closed: March 7, 2026

Award details

  • Expected project funding: $3,000,000
  • Expected awards: 6

Award min.

Not specified

Award max.

$500,000

  • Funding opportunity number:RFA-DK-26-306
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Health
  • Category Explanation:Not specified

History

  • Posted date: December 3, 2025
  • Archive date: April 10, 2026
  • Version: 1

View version history on Grants.gov

This funding opportunity is designed to support research in understanding how to engineer intrinsic characteristics of stem cell-derived islet cell products that can result in improved cell replacement therapy outcomes. Unlike cadaveric human islets, stem cell-derived islet cell products are generated from well-defined and highly controlled cell bank sources. Their banking, manufacturing, and quality control processes can be used to instill optimized cell characteristics resulting in more resilient and durable graft viability and function. This funding opportunity aims to stimulate studies on targets...

Eligibility

Government

  • Public and Indian housing authorities
  • State governments
  • Federally recognized Native American tribal governments
  • City or township governments
  • County governments
  • Special district governments

Miscellaneous

  • Other

Education

  • Independent school districts
  • Public and state institutions of higher education
  • Private institutions of higher education

Nonprofit

  • Nonprofits non-higher education with 501(c)(3)
  • Nonprofits non-higher education without 501(c)(3)
  • Other Native American tribal organizations

Business

  • For-profit organizations other than small businesses
  • Small businesses

Additional information on eligibility

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Documents

File nameDescriptionLast updated
RFA-DK-26-306-Full-Announcement.html
RFA-DK-26-306-Full-Announcement.html
Dec 3, 2025 07:54 PM UTC

Agency contact information

Email: NIDDK_DEM@nih.gov

NIDDK_DEM@nih.gov

Albert Hwa NIDDK_DEM@nih.gov

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov